Mylod%2525252525252525252525252525252525252525252525252525252525252525252525252525252525252520at

# Mylot%2525252525252525252525252525252525252525252525252525252525252525252525252525252525252520at ## Overview Mylot%2525252525252525252525252525252525252525252525252525252525252525252525252525252525252520at is a brand name for **clobetasol propionate**, a potent topical corticosteroid. It works by suppressing inflammation, itching, and redness. ## Primary Indications * Inflammatory dermatoses unresponsive to less potent corticosteroids (e.g., psoriasis, recalcitrant eczema). ## Adult Dosing * **Cream/Ointment/Solution:** Apply a thin layer to affected areas **once or twice daily**. * **Scalp Application:** Apply to the affected scalp areas **once or twice daily**. * **Foam:** Apply a small amount to the affected scalp areas **once or twice daily**. * **Maximum Use:** Generally limited to 50g per week for 2 weeks. Long-term use is not recommended due to potential for side effects. ## Pediatric Dosing Use in pediatric patients is generally not recommended due to increased risk of systemic absorption and adverse effects. If used, it should be under strict medical supervision for short durations on limited areas. Specific pediatric dosing is not established and depends on clinical judgment and local protocols. ## Dose Adjustments * **Renal Impairment:** No specific dose adjustment guidelines are established for topical administration. * **Hepatic Impairment:** No specific dose adjustment guidelines are established for topical administration. ## Contraindications * Hypersensitivity to clobetasol propionate or any component of the formulation. * Untreated bacterial, fungal, or viral skin infections. * Rosacea and perioral dermatitis. * Acne vulgaris. ## Adverse Effects * **Local:** Burning, itching, irritation, stinging, thinning of the skin (atrophy), striae, telangiectasias, acneiform eruptions, hypopigmentation. * **Systemic (with prolonged, extensive use, or occlusion):** Cushing's syndrome, hyperglycemia, glucosuria, adrenal suppression. ## Key Drug Interactions Systemic absorption can be increased when used with occlusive dressings, increasing the risk of interactions with other systemic medications. No significant topical-to-topical interactions are commonly reported, but avoid concurrent use of other potent topical corticosteroids. ## Monitoring * Monitor for signs of local adverse effects (skin thinning, striae). * Monitor for signs of systemic absorption (e.g., Cushingoid symptoms, adrenal suppression) with prolonged or extensive use, especially in children or under occlusion. ## Clinical Pearls * Mylot%2525252525252525252525252525252525252525252525252525252525252525252525252525252525252520at is a high-potency corticosteroid and should be reserved for severe, recalcitrant conditions. * Use the lowest effective strength and duration to minimize adverse effects. * Occlusion increases penetration and potency but also the risk of adverse effects. * Avoid use on the face, groin, and axillae unless specifically indicated and for short durations due to increased risk of side effects. *** *Disclaimer: This information is intended for healthcare professionals. Always verify current prescribing information and consult official drug compendia for the most up-to-date and complete details.*